Multi drug resistance pattern of Escherichia coli isolated from urinary tract infected (UTI’s) patients
Keywords:
E. coli, urinary tract infection, multi drug resistanceAbstract
A urinary tract infection predominates commonly in outpatients as well as in hospitalized patients worldwide. Another, health concern problem is multi drug resistance towards antibacterial drugs which is an alarming situation to medical practitioners. Escherichia coli (E. coli) are the commonest causative and etiologic agent in urinary tract infection. Of the total 182 isolated uropathogens E. coli were the most prevalent bacteria which accounts for 29.12% (53/182) and also high percentage was observed in females 69.78% (127/182). All of these isolates were tested against 14 different antibiotics. E. coli showed tremendous resistance towards Amoxyclav 90.56% followed by Ampicillin, 86.79%, Ciprofloxacin, 83.01%, Nalidixic acid, 79.24%, Cefodoxime, 75.47%, Cephalothin, 71.69%, Tetracycline, 69.81%, Gentamicin, 49.05%, Ceftazidime/clavulanic acid, 45.28%, Ceftriaxone, 41.50%, Amikacin, 24.52%, Cefepime, 20.75% and Cefperazone/sulbactum, 13.20%. While Imipenem, is the prominent drug of choice for urinary tract infections.
Downloads
References
1. Adwan K, Abu HN, Adwan G, Jarrar N, Abu-Shanab B, Al- Masri M (2004) Molecular epidemiology of antibiotic- resistant Escherichia coli isolated from hospitalized patient with urinary tract infection in Northern Palestine. Polish Journal of Microbiology, 53: 23-26.
2. Ahmad AS, Syed SA, Mohiruzzaman A, Abu NIS, Mohammad RAM (2009) Changing trends in uropathogens and their antimicrobial sensitivity pattern. Bangladesh Journal of Medical Microbiology, 3(1): 9-12.
3. Akram M, Shahid M, Khan AU (2007) Etiology and antibiotic resistance patterns of community acquired urinary tract infections in JNMC Hospital Aligarh, India. Annals of Clinical Microbiology and Antimicrobial, 6: 274-276.
4. Bauer AW, Kirby WMM, Sherris JC, Turk M (1966) Antibiotic susceptibility testing by a standardized single disk method. American Journal of Clinical Pathology, 45: 493-496.
5. Bell JM, Turnidge JD, Gales AC, Pfaller M, Jones RN (2002) Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998–99). Diagnostic Microbiolology and Infectious Disease, 42: 193–198.
6. Clinical and Laboratory Standards Institute (2006) Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Information Supplement. CLSI document M100-S17, Clinical and Laboratory Standards Institute Wayne Pennsylvania.
7. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Canton R, Nordmann P (2008) Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerging Infectious Diseases, 14: 195-200.
8. Dash SK, Chakraborty SP, Mandal D, Roy S (2012) Isolation and characterization of multi drug resistant uropathogenic Escherichia coli from urine samples of urinary tract infected patients. International Journal of Life Science and Pharma Research, 2 (1): 25-39.
9. Dromigny JA, Nabeth P, Juergens-Behr A, Perrier-Gros-Claude JD (2005) Risk factors for antibiotic resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal. Journal of Antimicrobial Chemotherapy, 56: 236–239.
10. El Kholy A, Baseem H, Hall G, Procop GW, Longworth DL (2003) Antimicrobial resistance in Cairo, Egypt 1999–2000: a survey of five hospitals. Journal of Antimicrobial Chemotherapy, 51: 625–630.
11. Erb A, Stürmer T, Marre R, Brenner H (2007) Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. European Journal of Clinical Microbiology and Infectious Diseases, 26: 83–90.
12. Farshad S, Ranjbar R, Anvarinejad M, Shahidi M, Hosseini M (2010) Emergence of multi drug resistant strains of Escherichia coli isolated from urinary tract infection. The Open Conference Proceedings Journal, 1: 192-196.
13. Feng P, Weagant S, Grant M (2002) Enumeration of Escherichia coli and coliform bacteria. Bacteriology Analysis Manual, (8th edition) FAD/Centre for Food Safety and Applied Nutrition.
14. George FD, Gbedema YS, Agyare C, Adu F, Boamah EV, Tawiah AA, Saana MS (2012) Antibiotic resistance pattern of Escherichia coli isolates from hospitals in Kumasi, Ghana. International Scholarly Research Network. 2012: 1-5.
15. Islam MS, Khondkar P, Islam MA (2010) Isolation and in vitro antibiotic resistance and susceptibility pattern of a strain of E. coli. Bangladesh Pharmaceutical Journal. 13(1):34-37.
16. Kashef N, Djavid GE Shahbazi S (2010) Antimicrobial susceptibility patterns of community-acquired uropathogens in Tehran. Iranian Journal of Infection in Developing Countries. 4(4): 202–206.
17. Khadri H and Alzohairy M (2009) High prevalence of multi-drug-resistance (MDR) and extended spectrum beta lactamases (ESBL) producing bacteria among community acquired urinary tract infections (CAUTI), Journal of Bacteriology Research, 1(9): 105-110.
18. Kifferr CR, Mendes C, Oplustil CP, Sampaio JL (2007) Antibiotic resistance and trend of urinary pathogens in general outpatients from a major urban city. International Brazilian Journal of Urology, 33(1): 42-49.
19. Manges AR, Natarajan P, Solberg OD, Dietrich PS, Riley LW (2006) The changing prevalence of drug-resistant Enterobacteriaceae groups in a community: evidence for community outbreaks of urinary tract infections. Epidemiology and Infection, 134: 425–431.
20. Manjunath GN, Praksh R, Vamseedhar A, Shetty K (2011) Changing trends in the spectrum of antimicrobial drug resistance pattern of uropathogens isolated from hospitals and community patients with urinary tract infections in Tumkur and Bangalore, International Journal of Biological and Medical Research, 2(2): 504-507.
21. Melaku S, Kibret M, Abera B, Gebre S (2012) Antibiogram of nosocomial urinary tract infections in Felege Hiwot referral hospital, Ethiopia. African Health Science, 12 (2): 134- 139.
22. Mulla S, Charan J, Panvala T (2011) Antibiotic sensitivity of Enterobacteriaceae at a tertiary care center in India. Chronicles of Young Scientists, 2 (4): 214-218.
23. Ogura Y, Ooka T, Iguchi A, Toh H, Asadulghani M, Oshima K, Kodama T, Abe H, Nakayama K, Kurokawa K, Tobe T, Hattori M, Hayashi T (2009) Comparative genomics reveal the mechanism of the parallel evolution of O157 and non- O157 enterohemorrhagic Escherichia coli, Proceedings of the National Academy of Sciences of the United States of America, 106: 17939–17944.
24. Rawat V, Umesh, Paul P (2010) Antibiotic resistance pattern of urinary tract isolates of Escherichia coli from Kumaun region. National Journal of Integrated Research in Medicine, 1(4): 43-46.
25. Samra KSS, Cenk S, Horu G, Mehmet G, Beril O (2005) Increasing antimicrobial resistance of Escherichia coli isolates from community acquired UTI during 1998-2003 in Manisa Turkey, Japan Journal of Infectious Disease. 58: 159-161.
26. Shames SR, Auweter SD, Finlay BB (2009) Co-evolution and exploitation of host cell signalling pathways by bacterial pathogens. International Journal of Biochemistry and Cell Biology, 41: 380–389.
27. Steadman R and Topley N (1998) The virulence of Escherichia coli in Urinary tract. Chapter 3. In: Brumfit W, Jercmy MT, Hamilteon Miller Eds. Urinary tract infections. 1st ed. Chapman and Hall Publication, London. 37-41.
28. Turner SM, Scott-Tucker A, Cooper LM, Henderson IR (2006) Weapons of mass destruction: virulence factors of the global killer enterotoxigenic Escherichia coli. FEMS Microbiology Letters, 263(1): 10–20.
29. Wagenlehner FM, Naber KG, Weidner W (2008) Rational antibiotic therapy of urinary tract infections. Med Monatsschr Pharm, 3(1): 385–390.
30. Yengkokpam C, Ingudam D, Yengkokpam IS, Jha BK (2007). Antibiotic susceptibility pattern of urinary isolates in Imphal (Manipur), India, Nepal Medical College Journal, 9(3): 170-172.
31. Zahera M, Rastogi C, Singh P, Aram S, Khalid S, Kushwaha A (2011) Isolation, Identification and characterization of Escherichia coli from urine samples and their antibiotic sensitivity pattern. European Journal Experimental Biology 1(2): 118-124.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If the material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/
